Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+ early breast cancer undergoing trastuzumab-based therapy.
3 September 2019 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
BKH St Johann in Tirol, St Johann in Tirol (Austria)
18 More presentations in this session
Access the full session
The Event
ESC Congress 2019
3 September 2019
14:00 CET
You may be interested in
Congress Presentation
Congress Session
Congress Presentation
